Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28
PRO-nCOV-1003
Phase 2 mab completed
Quick answer
Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 for COVID-19 is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- mab
- Status
- completed